Joint Formulary & PAD

Committees : Surrey Priorities Committee

Profiles (0)

No records returned.

Committee Recommendations (1)

04 Mar 15
The Surrey Priorities Committee has considered the PCN evidence review and the NICE ESNM40 (Evidence Summary: New Medicine), regarding dapoxetine for the treatment of premature ejaculation:

The commissioning of dapoxetine for premature ejaculation is considered LOW PRIORITY and it is not recommended for routine prescribing.

Dapoxetine should therefore have a BLACK status on the Surrey traffic light system.